{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:13:16Z","timestamp":1792523596948,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.kint.2026.06.036","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:35:32Z","timestamp":1784936132000},"page":"1283-1293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of CD68+ macrophages in relation to kidney outcomes in immunoglobulin light-chain amyloidosis"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-9333","authenticated-orcid":false,"given":"Muhammad Umaid","family":"Rauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Riefolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuf","family":"Razvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Mansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awais","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5163-2441","authenticated-orcid":false,"given":"Jack","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldostefano","family":"Porcari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Rowczenio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawah","family":"Wurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver C.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahanzaib","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Bomsztyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Rezk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Martinez-Naharro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh D.","family":"Wechalekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian D.","family":"Gillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.06.036_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2026.06.036_bib2","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.kint.2026.06.036_bib3","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2026.06.036_bib4","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 1","key":"10.1016\/j.kint.2026.06.036_bib5","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.amjmed.2022.01.003","article-title":"Renal amyloidosis: presentation, diagnosis, and management","volume":"135","author":"Gurung","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2026.06.036_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.2010.08503.x","article-title":"Regression of gastroduodenal amyloid deposition in systemic AL amyloidosis after intensive chemotherapies","volume":"153","author":"Katoh","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2026.06.036_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gut.42.5.727","article-title":"The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients","volume":"42","author":"Lovat","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.kint.2026.06.036_bib8","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2169\/internalmedicine.53.2065","article-title":"Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after high-dose melphalan therapy with stem cell transplantation","volume":"53","author":"Katoh","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.kint.2026.06.036_bib9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3324\/haematol.2008.004119","article-title":"Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain","volume":"94","author":"van","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.kint.2026.06.036_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","article-title":"Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component","volume":"323","author":"Hawkins","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.06.036_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/cs0870289","article-title":"Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo","volume":"87","author":"Hawkins","year":"1994","journal-title":"Clin Sci"},{"key":"10.1016\/j.kint.2026.06.036_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s002590050273","article-title":"Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation","volume":"25","author":"Rydh","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.kint.2026.06.036_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1487250","article-title":"Neutrophils enhance the clearance of systemic amyloid deposits in a murine amyloidoma model","volume":"15","author":"Hancock","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2026.06.036_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ajpath.2019.01.011","article-title":"Macrophage-mediated phagocytosis and dissolution of amyloid-like fibrils in mice, monitored by optical imaging","volume":"189","author":"Richey","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2026.06.036_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature09494","article-title":"Antibodies to human serum amyloid P component eliminate visceral amyloid deposits","volume":"468","author":"Bodin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.kint.2026.06.036_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3128","article-title":"Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis","volume":"10","author":"Richards","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.kint.2026.06.036_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-5320(70)80005-3","article-title":"Immunophagocytosis of human amyloid fibrils by leukocytes","volume":"32","author":"Zucker-Franklin","year":"1970","journal-title":"J Ultrastruct Res"},{"key":"10.1016\/j.kint.2026.06.036_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid","volume":"389","author":"Garcia-Pavia","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.06.036_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13506129.2024.2420809","article-title":"PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study","volume":"32","author":"Suhr","year":"2025","journal-title":"Amyloid"},{"key":"10.1016\/j.kint.2026.06.036_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2025.101299","article-title":"Suppression to removal, an emerging therapeutic approach for AL amyloidosis: a comprehensive review with early human data and pharmacokinetics of CAEL-101 antibody","volume":"73","author":"Ashfaque","year":"2025","journal-title":"Blood Rev"},{"key":"10.1016\/j.kint.2026.06.036_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2016.116","article-title":"CD68\/macrosialin: not just a histochemical marker","volume":"97","author":"Chistiakov","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.kint.2026.06.036_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41408-020-00355-6","article-title":"Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy","volume":"10","author":"Milani","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.kint.2026.06.036_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2017-02-767475","article-title":"AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis","volume":"130","author":"Dittrich","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.kint.2026.06.036_bib24","first-page":"3032","article-title":"Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosis","volume":"110","author":"Rauf","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.kint.2026.06.036_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.kint.2026.06.036_bib26","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.kint.2026.06.036_bib27","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/gfab250","article-title":"Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"37","author":"Casal Moura","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"4S","key":"10.1016\/j.kint.2026.06.036_bib28","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.06.036_bib29","article-title":"Role of macrophages and related cytokines in kidney disease","volume":"8","author":"Cantero-Navarro","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.kint.2026.06.036_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"Meng","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.06.036_bib31","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/ndt\/gfw260","article-title":"Macrophages in diabetic nephropathy in patients with type 2 diabetes","volume":"32","author":"Klessens","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.06.036_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1797.2006.00576.x","article-title":"Macrophage accumulation in human progressive diabetic nephropathy","volume":"11","author":"Nguyen","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2026.06.036_bib33","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1046\/j.1523-1755.2001.0590051626.x","article-title":"Role of immunocompetent cells in nonimmune renal diseases","volume":"59","author":"Rodriguez-Iturbe","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.06.036_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ndt\/gfm694","article-title":"Macrophages contribute to the development of renal fibrosis following ischaemia\/reperfusion-induced acute kidney injury","volume":"23","author":"Ko","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.06.036_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ekir.2022.11.015","article-title":"High macrophage densities in native kidney biopsies correlate with renal dysfunction and promote ESRD","volume":"8","author":"Pfenning","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.06.036_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40620-015-0252-7","article-title":"Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis","volume":"30","author":"Dias","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/j.kint.2026.06.036_bib37","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/labinvest.3700161","article-title":"AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells","volume":"84","author":"Keeling","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.kint.2026.06.036_bib38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ndt\/gfw443","article-title":"Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies","volume":"33","author":"Mariani","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2026.06.036_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","article-title":"Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy","volume":"122","author":"Lachmann","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2026.06.036_bib40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.2010.30.5235","article-title":"Outcome in renal AL amyloidosis after chemotherapy","volume":"29","author":"Pinney","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.kint.2026.06.036_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejr.2021.10.003","article-title":"Clinical utility of urinary soluble CD163 in evaluation of lupus nephritis patients","volume":"44","author":"Gamal","year":"2022","journal-title":"Egypt Rheumatol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826006071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826006071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:34:05Z","timestamp":1792488845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826006071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0085253826006071"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.06.036","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of CD68+ macrophages in relation to kidney outcomes in immunoglobulin light-chain amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.07.029","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}